An Adaptive Phase I/II Randomized Placebo-controlled Trial to Determine Safety, Immunogenicity and Efficacy of Non-replicating ChAdOx1 SARS-CoV-2 Vaccine in South African Adults Living Without HIV; and Safety and Immunogenicity in Adults Living With HIV
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00007137/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
A Phase I/II, double-blinded, placebo-controlled, individually randomized trial to assess
safety, immunogenicity and efficacy of the candidate Coronavirus disease (COVID-19) vaccine
ChAdOx1 nCoV-19 in adults aged 18-65 years living with and without HIV in South Africa. The
vaccine or placebo will be administered via an intramuscular injection into the deltoid
muscle of the non-dominant arm.
提供机构：
Vivli
创建时间：
2021-05-12
